Merck spin-off Organon, a global women’s health pharma company that launched earlier this year, is launching its first awareness campaign to raise awareness and ignite a worldwide conversation about the staggering rates of unplanned pregnancy around the world.
Worldwide, unplanned pregnancy impacts approximately 121 million women each year. A 2019 study reported that globally, more than 1 billion women have a need for family planning, but for 270 million of them, the need for modern methods of family planning is unmet. Unplanned pregnancy can impact any woman anywhere, regardless of her social or economic background.
“While we have seen a lot of progress in the area of reproductive health, the rates of unplanned pregnancy around the world continue to be high,” said Dr. Sandy Milligan, M.D., J.D., head of Organon research and development. “There is no better time than ahead of World Contraception Day to focus on empowering women through education, information, empathy and conversation to help reduce unplanned pregnancy.”
Organon invites women, their families, healthcare professionals and policy makers to visit hereforherhealth.com/unplanned to share their perspectives on how to help reduce the rates of unplanned pregnancy and join the on a collective mission of having the conversation.
“Now, more than ever, it is critical to focus on the reproductive well-being of all people,” said Dr. Raegan McDonald-Mosley, MD, CEO of Power to Decide. “On World Contraception Day, we have a unique opportunity to highlight the importance of ensuring all people – regardless of who they are, where they live, or their economic background – have the opportunity to decide if, when and under what circumstances to get pregnant or have a child.”
The ad will air on local TV and radio markets throughout the U.S., be distributed on social media via a variety of global channels and partners.
